Institutional investors control 15.45% of the outstanding shares in AZN. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended December 2017, these large investors purchased a net $9.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.8 Million shares of AstraZeneca PLC
PRIMECAP MANAGEMENT CO. Bought 2.6 Million shares of AstraZeneca PLC
ALYESKA INVESTMENT GROUP LP Bought 2.4 Million shares of AstraZeneca PLC